You are here

eczema

Upcoming events – Ascendis and Lilly hope for growth with pivotal data

EP Vantage

Fri, 02/1/19 - 11:58 am

clinical trials

pediatric growth hormone deficiency

Hoth Therapeutics seeks IPO cash to battle eczema

Fierce Biotech

Fri, 10/12/18 - 10:21 am

Hoth Therapeutics

Sanofi unveils eczema drug data, as regulators mull label expansion

Pharmaforum

Mon, 09/17/18 - 11:16 am

atopic dermatitis

Zai Lab bombs Phase IIa trial in atopic dermatitis, junks the program to shift resources to the pipeline

Endpoints

Sat, 08/25/18 - 09:38 pm

clinical trials

2 Biotech Stocks Near All-Time Highs: Can They Keep Climbing?

Motley Fool

Mon, 03/19/18 - 11:41 am

Sanofi and Regeneron's Dupixent launch is about to get a cash infusion

Fierce Pharma

Wed, 01/10/18 - 10:07 am

Pfizer's Eucrisa beats Dupixent to the DTC punch in eczema, thanks to first-to-market status

Fierce Pharma

Wed, 08/23/17 - 11:21 am

Dermira Commits $135M for Global Rights to Roche Eczema Drug

Xconomy

Tue, 08/8/17 - 11:15 pm

Sanofi's eczema rollout Dupixent hits blockbuster launch trajectory as earnings beat

Fierce Pharma

Mon, 07/31/17 - 10:19 pm

Analyst: Payer hurdles hit dispense rates on Sanofi and Regeneron's eczema blockbuster-to-be Dupixent

Fierce Pharma

Sun, 07/16/17 - 02:53 pm

Just what Sanofi and Regeneron wanted: A Dupixent rollout so zippy, it's fueling bigger sales forecasts

Fierce Pharma

Mon, 05/8/17 - 11:38 am

Sanofi Genzyme hit with patent lawsuit over new eczema drug

Bizjournals.com

Thu, 04/20/17 - 09:48 am

Regeneron's Game-Changing New Eczema Drug Could Be a Blockbuster

Motley Fool

Thu, 03/30/17 - 09:39 am

Can a $37,000 price be right? For Dupixent, analysts (and one payer) say yes

Fierce Pharma

Wed, 03/29/17 - 11:58 am

FDA approves Regeneron, Sanofi $37,000 per year eczema drug

Yahoo/Reuters

Tue, 03/28/17 - 12:28 pm

Crunch week looms for Sanofi, Roche and GSK at U.S. drugs agency

Yahoo/Reuters

Thu, 03/23/17 - 09:32 am

Sanofi, Regeneron Sue Amgen to Avoid Dupixent Patent Claims

Investopedia

Wed, 03/22/17 - 09:58 am

Sanofi, Regeneron say latest Dupixent eczema drug tests positive

Yahoo/Reuters

Sat, 03/4/17 - 01:54 pm

clinical trials

Novartis bags a new eczema drug, builds dermatology pipeline with Ziarco buyout

Endpoints

Fri, 12/16/16 - 11:34 am

FDA approves Pfizer ointment for chronic itchy skin condition

Yahoo/Reuters

Thu, 12/15/16 - 10:04 am

Pages